+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Forecast 2024-2030- Product Image
Global Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Forecast 2024-2030- Product Image
Sale

Global Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989916
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Therapy Market size was estimated at USD 8.66 billion in 2023, USD 9.60 billion in 2024, and is expected to grow at a CAGR of 10.93% to reach USD 17.91 billion by 2030.

The cell therapy market encompasses the research, development, manufacturing, and commercialization of products and techniques aimed at treating, mitigating, or preventing diseases by administering living cells. The escalating demand for regenerative medicine and advancements in cellular therapeutics primarily drives the growth of the cell therapy market.

The rising investment in research and development and collaborative efforts between pharmaceutical companies and research institutions have accelerated the pipeline for cell therapy products. Furthermore, supportive regulatory frameworks and the designation of fast-track approvals for groundbreaking therapies have been crucial growth stimulants for the market.

However, the cell therapy market faces several limitations, such as the high cost of therapies, intricate manufacturing processes, and stringent regulatory requirements, which may slow down market entry. Issues related to the preservation, transport, and shelf-life of cell therapies also present substantial challenges in the market growth. Moreover, breakthroughs in gene editing technologies such as CRISPR/Cas9 have opened new avenues for targeted cell therapies, which could offer precision medicine solutions for previously untreatable conditions. The increasing adoption of 3D bioprinting and artificial intelligence for optimizing cell therapy production holds significant promise for future market expansion.

Regional Insights

In the Americas region, the United States and Canada lead in cell therapy advancements, driven by significant research, heavy investment, and active participation from biotechnological and pharmaceutical giants. The regulatory framework in the region allows for an expedited review of novel cell therapies, hastening up the process of bringing new treatments to market. The European countries exhibit a cooperative approach towards cell therapy research, with various cross-country partnerships and funding programs supported by public and private sectors. Customer behavior in the EU is influenced by a strong predisposition towards state-funded healthcare systems, which affects access to and affordability of cell therapies.

The Middle East and Africa (MEA) present a diverse picture, with countries such as Israel, UAE, and Saudi Arabia taking strides in cell therapy, while many African nations are still developing capabilities in this area. In the APAC region, the governments in China, India, and Japan have initiated several investments and reforms to fast-track local cell therapy research and commercialization. The rising prevalence of cancers and genetic diseases in the region is significantly increasing the need for cell-based therapies for disease management.

Market Trends by Segment

  • Cell Type: Advancements in stem cells for therapeutic applications
  • Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines
  • Application: Advancements in dermatological applications of cell therapies
  • End-User: Diverse applications of cell therapies in hospitals and clinics for disease management

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Pluri Launches New Cell Therapy CDMO Division

Pluri, has expanded its operations by launching a new division, PluriCDMO, specializing in contract development and manufacturing services for the cell therapy sector. The division boasts a wealth of experience in key areas such as analytical development, process scale-up, and regulatory-approved comparability studies. Utilizing their proprietary bioreactor system for 3D cell expansion and the PluriMatrix technology, Pluri ensures high-volume, consistent, and scalable production of cell-based products.

Max Healthcare Launches CAR-T Cell Therapy to Improve Cancer Care in Delhi-NCR

Max Healthcare announced the launch of Chimeric Antigen Receptor T-cell (CAR-T) therapy, a revolutionary cancer treatment, now accessible at its Delhi-NCR facilities. This advanced therapy involves reprogramming a patient's T cells to target and eradicate cancer cells. The enablement of this treatment follows ImmunoACT's recent regulatory approval by India's Central Drugs Standard Control Organisation for its CAR-T cell product, indicating a major stride in innovative cancer care.

Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale

Bayer AG has announced the inauguration of a pioneering Cell Therapy Launch Facility in Berkeley, California to expand its business operations. Designed with sustainability in mind as Bayer's first fully electric pharmaceutical manufacturing plant, this biotechnological hub underscores the company's commitment to pushing the frontiers of medicine by supporting the transition from lab to commercial scale for revolutionary treatments

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Astellas Pharma Inc., Athersys, Inc., BioNTech SE, Bone Therapeutics SA, Bristol-Myers Squibb Company, Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc., Lonza Group Ltd., Medipost Co., Ltd., Mesoblast Ltd., Novartis AG, NuVasive, Inc., Pfizer Inc., Sartorius AG, Smith & Nephew PLC, Stemedica Cell Technologies, Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, TegoScience, Thermo Fisher Scientific, Inc., and Vericel Corporation.

This research report offers invaluable insights into various crucial aspects of the Cell Therapy Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
5.1.1.2. Improvements in Cell Therapy Supply Chain
5.1.2. Restraints
5.1.2.1. Side Effects Related to the Stem Cell Transplant
5.1.3. Opportunities
5.1.3.1. Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
5.1.3.2. Increasing Use of Stem Cells for the Treatment of Neurological disorders
5.1.4. Challenges
5.1.4.1. Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues
5.2. Market Segmentation Analysis
5.2.1. Cell Type: Advancements in stem cells for therapeutic applications
5.2.2. Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines
5.2.3. Application: Advancements in dermatological applications of cell therapies
5.2.4. End-User: Diverse applications of cell therapies in hospitals and clinics for disease management
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Cell Therapy Market, by Cell Type
6.1. Introduction
6.2. Differentiated Cell
6.3. Stem Cell
7. Cell Therapy Market, by Therapy Type
7.1. Introduction
7.2. Allogenic Therapies
7.3. Autologous Therapies
8. Cell Therapy Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Dermatology
8.4. Musculoskeletal Therapies
8.5. Oncology
9. Cell Therapy Market, by End-User
9.1. Introduction
9.2. Biotechnology and Pharmaceutical Companies
9.3. Hospitals and Clinics
9.4. Research Institutes
10. Americas Cell Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Therapy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Pluri Launches New Cell Therapy CDMO Division
13.3.2. Max Healthcare Launches CAR-T Cell Therapy to Improve Cancer Care in Delhi-NCR
13.3.3. Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CELL THERAPY MARKET RESEARCH PROCESS
FIGURE 2. CELL THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL THERAPY MARKET DYNAMICS
FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 63. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 64. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 65. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 66. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 67. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 70. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 71. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 72. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 73. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 74. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 75. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 108. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 109. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 110. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 111. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 114. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 115. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 116. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 117. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 118. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 119. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 132. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 133. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 134. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 135. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 180. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 181. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 182. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 183. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 205. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 206. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 207. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 208. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 209. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 214. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 215. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 216. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 217. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 222. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 223. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 224. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 225. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 230. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 231. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 232. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 233. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 238. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 239. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 240. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 241. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 254. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 255. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 256. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 257. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 278. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 279. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 280. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 281. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 286. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 287. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 288. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 289. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 294. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 295. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 296. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 297. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 325. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 326. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 327. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 328. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 329. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 349. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 350. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 351. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 352. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 353. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 354. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 355. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 356. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 366. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
TABLE 368. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 370. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 372. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 373. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 374. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • Athersys, Inc.
  • BioNTech SE
  • Bone Therapeutics SA
  • Bristol-Myers Squibb Company
  • Castle Creek Biosciences, Inc.
  • FUJIFILM Holdings Corporation
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Kolon TissueGene, Inc.
  • Lonza Group Ltd.
  • Medipost Co., Ltd.
  • Mesoblast Ltd.
  • Novartis AG
  • NuVasive, Inc.
  • Pfizer Inc.
  • Sartorius AG
  • Smith & Nephew PLC
  • Stemedica Cell Technologies, Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • TegoScience
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.91 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Forecast 2024-2030 - Product Image

Global Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Global Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Forecast 2024-2030 - Product Image

Global Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Global Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion, Apheresis), By Type, By Scale, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion, Apheresis), By Type, By Scale, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 136 Pages
  • Global
From
Global Cell Therapy Technologies Market by Therapy Type, Therapeutic Area, Region - Forecast up to 2030 - Product Image

Global Cell Therapy Technologies Market by Therapy Type, Therapeutic Area, Region - Forecast up to 2030

  • Report
  • 201 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.